Bloomin' Brands, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $BLMN in the last 30 days.
See all $BLMN insider activity →Zacks upgraded five stocks to Strong Buy: RCM Technologies (RCMT), Healthcare Services Group (HCSG), Bloomin' Brands (BLMN), Argan (AGX), and Globus Medical (GMED). Their earnings estimates rose 13.3%, 12.9%, 10.1%, 6.7%, and 5.3% respectively in 60 days.
Gordon Haskett analyzed 2026 estimate revisions for 22 restaurant companies, finding 9 saw upward revisions, 3 held steady, and 10 faced downward revisions. Cheesecake Factory, Bloomin’ Brands, BJ’s Restaurants, and Starbucks saw upward revisions across all metrics, while Papa Johns, Wendy’s, and others saw downward revisions. The sector gained 6% over 12 months, underperforming the S&P 500's 18% gain. Revisions to same-store sales had the strongest correlation with share price moves.
Bloomin' Brands (NASDAQ:BLMN) reported Q2 FY2026 revenues of $1.02B, up 1%, and adjusted diluted EPS of $0.39, up 22%. U.S. comparable sales rose 1% with positive 2.3% comps offset by traffic down 1.9%. Full-year adjusted EPS guidance raised to $0.90-$1.00. Outback comps +1.4%, Carrabba's +1.7%, Bonefish +8.1%.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning BLMN (Bloomin' Brands, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent BLMN coverage spans earnings, financial news and sector analysis.
Could spark brief buying interest.
Positive estimate revisions may support price appreciation.
Guidance raise plus margin and turnaround progress suggests improving earnings power, but traffic softness and negative tax rate outlook add risk.
Management is signaling improving guest metrics and positive comp momentum at multiple brands, with specific operational changes at Outback.
Guidance upside supports the turnaround narrative, but the guided Q3 loss and ongoing labor and input inflation keep near-term margin risk elevated.
AlphAI scores every news story that mentions BLMN with an AI model for sentiment and relevance, and aggregates insider trades from Bloomin' Brands, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Zacks upgraded five stocks to Strong Buy: RCM Technologies (RCMT), Healthcare Services Group (HCSG), Bloomin' Brands (BLMN), Argan (AGX), and Globus Medical (GMED). Their earnings estimates rose 13.3%, 12.9%, 10.1%, 6.7%, and 5.3% respectively in 60 days.
1 min readGordon Haskett analyzed 2026 estimate revisions for 22 restaurant companies, finding 9 saw upward revisions, 3 held steady, and 10 faced downward revisions. Cheesecake Factory, Bloomin’ Brands, BJ’s Restaurants, and Starbucks saw upward revisions across all metrics, while Papa Johns, Wendy’s, and others saw downward revisions. The sector gained 6% over 12 months, underperforming the S&P 500's 18% gain. Revisions to same-store sales had the strongest correlation with share price moves.
2 min readBloomin' Brands (NASDAQ:BLMN) reported Q2 FY2026 revenues of $1.02B, up 1%, and adjusted diluted EPS of $0.39, up 22%. U.S. comparable sales rose 1% with positive 2.3% comps offset by traffic down 1.9%. Full-year adjusted EPS guidance raised to $0.90-$1.00. Outback comps +1.4%, Carrabba's +1.7%, Bonefish +8.1%.
6 min readBloomin' Brands (BLMN) discussed Q2 2026 results on an earnings call, highlighting Outback, Carrabba's, Bonefish, and Fleming's comparable sales and traffic trends. Outback guest metric scores rose year over year, and U.S. comp sales were positive 230 bps with traffic down 190 bps. The company outlined an Outback turnaround plan, including a new service model and increased marketing spend.
7 min readBloomin' Brands (BLMN) reported Q2 revenue of $1,015.81 million and net income of $31.34 million. The company raised 2026 diluted EPS guidance to $0.85 to $0.95 and guided Q3 diluted EPS loss of $0.28 to $0.23, citing menu streamlining and value-focused offerings. The update supports its turnaround and cost-efficiency narrative.
3 min readBloomin' Brands, owner of Outback Steakhouse, raised full-year guidance. GAAP EPS is now 85 to 95 cents, up from 70 to 85 cents, versus a 85-cent estimate. Adjusted EPS is 90 cents to $1, up from 75 cents to 90 cents, versus 87 cents. For Q3 it expects adjusted and GAAP losses of 27 to 22 cents and 28 to 23 cents. It forecasts U.S. comparable sales growth of 1% to 2%.
4 min readBloomin' Brands (NASDAQ:BLMN) reported Q2 chain performance: Outback guest metrics improved for a fourth straight quarter, with service model changes and higher top-box scores. Carrabba's comparable sales rose 1.7% but traffic fell 2.5%; Bonefish Grill comparable sales rose 8.1% with traffic up 4.5%; Fleming's comparable sales rose 1.6% with traffic down 2.8%. The company raised 2026 adjusted diluted EPS guidance to $0.90-$1.00 and expects U.S. comps of 1%-2%.
6 min readBloomin' Brands (BLMN) reported quarterly revenue of $1.02B, net income of $31.34M, and diluted EPS of $0.36, versus $1.0B, $25.42M, and $0.30 a year earlier. Revenue rose 1.3% YoY. U.S. comparable sales gained 2.3% as traffic fell about 1.9%. Bonefish Grill comps were 8.1% and Outback 1.4%, with cost initiatives supporting margins.
1 min readBloomin’ Brands (NASDAQ: BLMN) reported Q2 2026 results showing higher earnings and improved margins, according to the company’s filings. The update covers performance across its restaurant and franchise segments and provides financial statement line items for the quarter ended June 28, 2026.
2 min readBloomin’ Brands shares rose about 35% to $12.04 midday Wednesday after Outback Steakhouse reported improving results. For the quarter ended June 28, Outback same-store sales rose 1.4% YoY, while traffic fell 2.8%. Bloomin’ raised its outlook, projecting companywide same-store sales growth of 1% to 2%. Total revenue rose 1.3% to just over $1B, with adjusted EPS up to 39 cents.
5 min read
